Cytoskeletal-antigen specific immunoliposome-targeted in vivo preservation of myocardial viability

Journal of Controlled Release

Volumn 120, Issue 1-2, 2007, Pages 35-40

  Khaw, Ban An ^a   DaSilva, Jose ^a   Hartner, William C ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Immunoliposomes; Myocardial infarction; Preservation of myocardial viability

Indexed keywords

IMMUNOLIPOSOMES; MYOCARDIAL INFARCTION; MYOCARDIAL VIABILITY;

ANTIGENS; CELL CULTURE; CELL MEMBRANES; ELECTROCARDIOGRAPHY; PHYSIOLOGICAL MODELS; TISSUE;

LIPOSOMES;

CYTOSKELETAL ANTIGEN SPECIFIC IMMUNOLIPOSOME; IMMUNOLIPOSOME; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CYTOSKELETON; DISEASE MODELS, ANIMAL; DRUG COMPOUNDING; ELECTROCARDIOGRAPHY; HEART VENTRICLES; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LIPIDS; LIPOSOMES; MYOCARDIAL INFARCTION; MYOSINS; NECROSIS; PHOSPHATIDYLCHOLINES; RABBITS;

EID: 34249951249     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.04.013     Document Type: Article

References (35)

1. Leist M., Single B., Castoldi A.F., et al. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185 (1997) 1481-1486
2. Eguchi Y., Shimizu S., and Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57 (1997) 1835-1840
3. Fischer S., MacLean A.A., Liu M., et al. Dynamic changes in apoptotic and necrotic cell death correlate with severity of ischemia-reperfusion in lung transplantation. Am. J. Respir. Crit. Care Med. 162 (2000) 1932-1939
4. Ohno M., Takemura G., Ohno A., et al. "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation. Circulation 98 (1998) 1422-1430
5. Majno G., and Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am. J. Pathol. 146 (1995) 3-15
6. Shi R., Qiao X., Emerson N., and Malcom A. Dimethylsulfoxide enhances CNS neuronal plasma membrane resealing after injury in low temperature or low calcium. J. Neurocytol. 30 9-10 (2001) 829-839
7. McNeil P.L. Repairing a torn cell surface: makeway, lysosomes to the rescue. J. Cell Sci. 115 Pt 5 (2002) 873-879
8. Togo T., Alderton J.M., and Steinhardt R.A. Long-term potentiation of exocytosis and cell membrane repair in fibroblasts. Mol. Biol. Cell 14 (2003) 93-106
9. McNeil P.L., and Ito S. Gastrointestinal cell plasma membrane wounding and resealing in vivo. Gastroenterology 96 5 Pt1 (1989) 1238-1248
10. Walev I., Hombach M., Bobkiewicz W., et al. Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-kappa B activation and downstream events. FASEB J. 16 2 (2002) 237-239
11. Dobrinina O.V., Shatinina Z., and Archakov A.I. Phosphatidylcholine liposomes in the repair of hepatocyte plasma membrane. Bull. Exp. Biol. Med. 110 (1990) 94-96
12. Wang C.Y., and Huang L. PH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7851-7855
13. Kono K., Iwamoto M., Nishikawa R., et al. Design of fusogenic liposomes using a poly(ethylene glycol) derivative having amino groups. J. Control. Release 68 (2000) 225-235
14. Kunisawa J., Masuda T., Katayama K., et al. Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release. J. Control. Release 105 (2005) 344-353
15. Khaw B.A., Torchilin V.P., Vural I., et al. Plug and seal: prevention of hypoxic cell death by sealing membrane lesions with cytoskeleton-specific immunoliposomes. Nat. Med. 1 (1995) 1195-1198
16. Khaw B.A., da Silva J., Vural I., et al. Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes. J. Control. Release 75 (2001) 199-210
17. Khudairi T., and Khaw B.A. Preservation of ischemic myocardial function and integrity with targeted cytoskeleton-specific immunoliposomes. J. Am. Coll. Cardiol. 4 (2004) 1683-1689
18. Narula J., Petrov A., Pak K.Y., et al. Very early non-invasive detection of acute experimental non-reperfused myocardial infarction with 99 m Tc-labeled glucarate. Circulation 95 6 (1997) 1577-1584
19. B.A. Khaw, T. Khudairi, Dose-response to cytoskeletal-antigen specific immunoliposome therapy for preservation of myocardial viability and function in Langendorff instrumented rat hearts. J. Liposome Res. (in press).
20. Brener S.J., and Topol E.J. Adjunctive therapy for percutaneous revascularization in acute myocardial infarction. Curr. Pharm. Des. 10 4 (2004) 399-405
21. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
22. Ockaili R.A., Bhargava P., and Kukreja R.A. Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial KATP channel. Am. J. Physiol, Heart Circ. Physiol. 280 (2001) H2406-H2411
23. Narula J., Nicol P.D., Southern J.F., et al. Evaluation of myocardial infarct size before and after reperfusion: dual-tracer imaging with radiolabeled antimyosin antibody. J. Nucl. Med. 35 (1994) 1076-1085
24. Huang J.Q., Radinovic S., Rezaiefar P., et al. In vivo myocardial infarct size reduction by caspase inhibitor administered after the onset of ischemia. Eur. J. Pharmacol. 402 (2000) 139-142
25. Kroemer G., and Martin S.J. Caspase-independent cell death. Nat. Med. 11 (2005) 725-730
26. Carter B.Z., Kornblau S.M., Tsao T., et al. Caspase-independent cell death in AML, caspase-inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis. Blood 102 (2003) 4179-4186
27. Vivaldi M.T., Kloner R.A., and Schoen F.J. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am. J. Pathol. 121 (1985) 522-530
28. Birnbaum Y., Hale S.L., and Kloner R.A. Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size as measured by triphenyltetrazolium chloride staining. J. Mol. Cell Cardiol. 29 (1997) 657-666
29. Kloner R.A., Ganote C.E., and Jennings R.B. The no-reflow phenomenon after temporary coronary occlusion in the dog. J. Clin. Invest. 54 (1974) 1496-1508
30. Fishbein M.C., Meerbaum S., Rit J., et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am. Heart J. 101 (1981) 593-600
31. Asahi M., Rammohan R., Sumii T., et al. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced haemorrhage after focal embolic stroke. J. Cereb. Blood Flow Metab. 8 (2003) 895-899
32. Kono K., Igawa T., and Takagishi. Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly (ethylene glycol) derivative. Biochim. Biophys. Acta 1325 (1997) 143-154
33. Hyndman L., Lemoine J.L., Huang L., et al. HIV-1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J. Control. Release 99 (2004) 435-444
34. Singh M., and Ariatti M. Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes. J. Control. Release 92 (2003) 383-394
35. Liang W., Levchenko T., Khaw B.A., et al. ATP-containing immunoliposomes specific for cardiac myosin. Curr. Drug Delivery 1 (2004) 1-7